EGFR and cancer: Since, EGFR activation up-regulated glycolysis in EGFR mutant cells but not in EGFR wild-type cancer cells and normal cells, thus, it is predictable that AMPK activation will suppress cell viability more in EGFR mutant cells and normal cells.